Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- UnitedHealth Group Incorporated
- Pfizer
Comparative performance (base 100)
Each asset is worth 100 at October 20, 2025; a value of 120 means +20% since that date (latest common date: October 16, 2026).
Bonds and private debt have no comparable price series: they appear only in the table.
Indicators
"Not applicable" indicates a metric that has no meaning for this type of asset: it should not be compared.
| Indicator | UnitedHealth Group IncorporatedStock | PfizerStock |
|---|---|---|
| Performance and risk | ||
| Performance over the periodChange in price between the first and last common dates. | Unavailable | +19.8% |
| Annualized performanceAverage annual return that would produce the same total performance. | Unavailable | +20.1% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | Unavailable | 21.5% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | Unavailable | −17.1% |
| Sharpe RatioReturn achieved above the risk-free rate (5.10%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | Unavailable | 0.83 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | Unavailable | −2.2% |
| Fundamentals | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 497.59B CAD | 168.6B $ |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 19.9 | 38.9 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 1.1 | 2.6 |
| Net marginShare of revenue retained as profit. | 4.0% | 6.8% |
| Return on equityReturn on equity (ROE). | 17.5% | 5.0% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +12.2% | +2.6% |
| Dividend yieldAnnual dividend relative to the share price. | 2.68% | 5.81% |
| Debt / equityFinancial debt relative to shareholders' equity. | 76% | 74% |
Information provided for educational purposes only. It does not constitute investment advice or a personalized recommendation. Past performance is no guarantee of future results.